Literature DB >> 10933393

Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities.

J L Xu1, M M Davis.   

Abstract

All rearranging antigen receptor genes have one or two highly diverse complementarity determining regions (CDRs) among the six that typically form the ligand binding surface. We report here that, in the case of antibodies, diversity at one of these regions, CDR3 of the V(H) domain, is sufficient to permit otherwise identical IgM molecules to distinguish between a variety of hapten and protein antigens. Furthermore, we find that somatic mutation can allow such antibodies to achieve surprisingly high affinities. These results are consistent with a model in which the highly diverse CDR3 loops are the key determinant of specificity in antigen recognition in both T cell receptors (TCR) and antibodies, whereas the germline-encoded CDR1 and CDR2 sequences are much more cross-reactive.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933393     DOI: 10.1016/s1074-7613(00)00006-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  278 in total

Review 1.  Regulation and chance in the ontogeny of B and T cell antigen receptor repertoires.

Authors:  Michael Zemlin; Robert L Schelonka; Karl Bauer; Harry W Schroeder
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Recruitment of a distinct but related set of VH sequences into the murine CD21hi/CD23- marginal zone B cell repertoire to that seen in the class-switched antibody response.

Authors:  Henry N White; Qing-Hai Meng
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

3.  Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display library.

Authors:  Peter Ellmark; Camilla Ottosson; Carl A K Borrebaeck; Ann-Christin Malmborg Hager; Christina Furebring
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

4.  Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation.

Authors:  Jacob Glanville; Tracy C Kuo; H-Christian von Büdingen; Lin Guey; Jan Berka; Purnima D Sundar; Gabriella Huerta; Gautam R Mehta; Jorge R Oksenberg; Stephen L Hauser; David R Cox; Arvind Rajpal; Jaume Pons
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

5.  Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization.

Authors:  Hongyuan Mao; James J Graziano; Tyson M A Chase; Cornelia A Bentley; Omar A Bazirgan; Neil P Reddy; Byeong Doo Song; Vaughn V Smider
Journal:  Nat Biotechnol       Date:  2010-10-24       Impact factor: 54.908

6.  Making antibodies from scratch.

Authors:  J Christopher Love
Journal:  Nat Biotechnol       Date:  2010-11       Impact factor: 54.908

7.  Immune responses are characterized by specific shared immunoglobulin peptides that can be detected by proteomic techniques.

Authors:  Martijn M VanDuijn; Lennard J M Dekker; L Zeneyedpour; Peter A E Sillevis Smitt; Theo M Luider
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

8.  Conversion of scFv peptide-binding specificity for crystal chaperone development.

Authors:  Jennifer C Pai; Jeffrey A Culver; Jason E Drury; Rakesh S Motani; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2011-01-08       Impact factor: 1.650

9.  Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors:  Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

10.  Production and Characterization of Neutralizing Antibodies against Bungarus multicinctus Snake Venom.

Authors:  Chi-Hsin Lee; Yu-Ching Lee; Sy-Jye Leu; Liang-Tzung Lin; Jen-Ron Chiang; Wei-Jane Hsu; Yi-Yuan Yang
Journal:  Appl Environ Microbiol       Date:  2016-09-23       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.